View up-to-date information on Astellas Gene Therapies’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
02 Dec 2019 | Astellas Pharma Acquires Audentes Therapeutics | Acquisition |
Astellas Pharma Inc
|
Astellas Gene Therapies |
08 Apr 2019 | Audentes Therapeutics Enters into Licensing Agreement with Nationwide Children's Hospital | Licensing Agreement |
Astellas Gene Therapies
|
Nationwide Children's Hospital
|
10 Oct 2018 | Audentes Therapeutics Prices Public Offering of Shares for USD150.8 Million | Equity Offering | - |
Astellas Gene Therapies |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer